The average P/S ratio for PRAX's competitors is 478.94, providing a benchmark for relative valuation. Praxis Precision Medicines Inc Corp (PRAX) exhibits a P/S ratio of 1577.94, which is 229.46% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.